The veterinarians on tour will also make sure that dog owners are aware of some of the common symptoms seen with heart disease: reduced willingness to walk or exercise, difficulty breathing, coughing, loss of appetite and weight loss. Dog owners can learn even more at www.yourdogsheart.com.
Midwest Mobile Dog Heart Health Tour ST. LOUIS: When: Friday, August 28, 2009, from 1 to 7 p.m. Where: Forest Park - Upper Muny Parking lot at Macklind & Union Drive CHICAGO: When: Sunday, August 30, 2009, from 12 noon to 6 p.m. Where: Puptown Dog Park - 4921 N. Marine Drive
About Congestive Heart Failure in Dogs
The makers of Vetmedin(R) - a break-through prescription drug now available in the United States to treat canine congestive heart failure - organized the Midwest Mobile Dog Heart Health Tour to teach people about congestive heart failure (CHF) in dogs.
While there is no cure for CHF, clinical study results have shown that dogs with the condition live nearly twice as long and enjoy a higher quality of life when treated with Vetmedin.
Boehringer Ingelheim Vetmedica, Inc. (BIVI, St. Joseph, Mo.) is the exclusive U.S. manufacturer of Vetmedin. BIVI is a subsidiary of Boehringer Ingelheim Corporation based in Ridgefield, Conn. and a member of the Boehringer Ingelheim group of companies.
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching
|SOURCE Boehringer Ingelheim Vetmedica, Inc.|
Copyright©2009 PR Newswire.
All rights reserved